The Centers for Disease Control and Prevention has released evidence-based recommendations to prevent and control Staphylococcus aureus in neonatal intensive care units, including strains resistant (MRSA) or sensitive (MSSA) to the antibiotic methicillin.

The recommendations supplement existing CDC recommendations for all health care settings based on a systematic review of the best available literature, the agency said.

“While MRSA has long been the focus of prevention efforts due to the difficulty in treating and eradicating it, recent studies have demonstrated that methicillin-sensitive S. aureus (MSSA) has morbidity and mortality equal to MRSA and occurs more frequently in NICU patients,” the guidelines note.

Headline
March 8-14 marks Patient Safety Awareness Week. The AHA has several resources including podcasts, videos and reports that show how AHA members are advancing…
Headline
The U.S. District Court for the Southern District of Florida March 6 ruled in favor of five Florida hospitals in a case challenging the methodology used by the…
Headline
The Centers for Disease Control and Prevention Feb. 26 announced that an infant botulism outbreak that sickened 48 babies who consumed ByHeart formula is over…
Headline
The measles outbreak in South Carolina has increased to 876 cases, the state’s Department of Public Health reported Feb. 3. Last week, the South Carolina…
Headline
The Food and Drug Administration has identified a Class I recall of certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus…
Headline
Thomas McGinn, M.D., senior executive vice president and chief physician executive officer at CommonSpirit Health, shares how the organization aligns…